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ABSTRACT 
The persistent uncertainty that looms over the search for solutions to health problems 
offers important conceptual insights for the study of technological change. This paper 
explores the notion of hybridization, namely the embodiment of multiple competing 
operational principles within a single medical device, as strategy to deal with the 
practical shortcomings due to said uncertainty. The history of the development of the 
hybrid artificial disk affords the elaboration of an alternative view of hybridization and, 
at the same time, the articulation of a dualism between medical science as area of basic 
research (e.g. what disease is) and as practical knowledge (e.g. how disease can be 
tackled). 
1. INTRODUCTION 
Over the last two decades scholars of technological change ventured in the study of 
innovation in the health-care realm. Seen through the lenses of this novel approach 
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medical innovation has been removed from the shadow of the ‘linear model’ framework 
that dominated science and technology studies in the early 1960s and cast under a new 
light. In a nutshell medical innovation is now understood as the outcome of a long-term 
learning process and analysed with a view to appreciate the incremental nature of a 
process unfolding in real time and under the uncertainty that typically, at least within 
innovation studies, underlies the translation of cognitive abilities into effective routines 
[1, 2]. The explicit recognition of temporality calls attention to path-dependence and the 
associated effects of advancing technological paradigms in locally familiar directions 
under the dual penumbra of positive increasing returns as well as the risk of lock-in 
within dynamically inferior configurations [3, 4]. In this view the growth and 
application of knowledge are bound, for good or for bad, to the “grip of history” (see [5] 
for a review). It follows, paraphrasing Simon [8], that the search for effective diagnostic 
and therapeutic avenues entails the pursuit of clearly defined goals through 
‘procedurally uncertain’ routes [9,10]. 
This paper seeks to draw on and contribute this debate by analyzing the hybridization of 
a medical device, namely the artificial disk that is implanted surgically to alleviate from 
the painful symptoms of Degenerative Disk Disease - a leading cause of back pain and 
disability worldwide. This case study affords the opportunity to explore the conceptual 
underpinnings of hybridization (viz. embodiment of competing operational principles 
within a single device) understood here as evolutionary response to persistent 
uncertainty about both the nature of disease and the comparative clinical performance of 
available therapeutic solutions. The analysis of the long-term development of the hybrid 
artificial disk elucidates broader aspects of medical innovation and, in so doing, 
contributes various strands of scholarly debate. First, the present paper suggests a novel 
perspective on hybridization, namely that making ‘available’ different operational 
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principles within a single device allows leaving some room for adjustments should 
future reconfigurations be warranted by enhanced scientific understanding [11]. This 
nuanced view of engineering epistemology [12] overcomes narrow interpretations of the 
concept of technological paradigm observed in past literature[13], in particular for what 
concerns the incommensurability of competing principles [14]. Second, the case study 
shows that different approaches to know-how can be effectively combined and 
compensate, at least partially, for limited know-what. Last but not least the paper makes 
an important addition to the growing catalogue of case studies on the dynamics of 
innovation in medicine [15, 16, 17, 18, 19, 20] by restating forcefully the sheer variety 
of routes through which the process emerges and develops in this realm. 
The remainder of the paper is organized as follows. Section 2 articulates the main 
conceptual elements of an evolutionary framework for knowledge growth and 
hybridization in medicine. Section 3 offers an overview of the scientific, clinical and 
technical aspects of uncertainty in Arthroplasty, the surgical implantation of a device to 
alleviate from the painful symptoms of Degenerative Disk Disease. Section 4 analyses 
in detail the development of the hybrid artificial disk and illustrates the fundamental 
relationship between hybridization and uncertainty. The last Section concludes and 
summarizes. 
2. BACKGROUND 
2.1 –UNCERTAINTY AND MEDICAL INNOVATION 
Commenting on the characteristics of innovation in medicine Richard Nelson [7, 21] 
argues that clinical routines are often implemented out of direct observation and in the 
face of imperfect understanding of the workings of disease. That is, the complex 
biochemistry of the body can at best guide the search process but the activities that are 
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ultimately adopted in the clinics stem from recursive application in the course of 
providing patient care. What is more, clinical procedures not necessarily based on solid 
understanding of disease unpredictably reveal promising directions for basic scientific 
research.
1
 In other cases observation of particular symptoms delimits the design space 
of therapeutics even though little is known about the aetiology of disease. In all these 
circumstances scientific instrumentation is crucial to enabling replicable 
experimentation for validating or refuting any particular solution [22]. 
The suggested functional separation between basic scientific knowledge – aimed at 
elucidating ‘know-what’ – and practical knowledge – viz. know-how for problem 
solving – places this perspective far from the traditional tenet of studies on health 
technology diffusion [7, 23, 24]. In recent years a stream of work along this alternative 
approach elucidated important nuances of the division between scientific and practical 
knowledge in medicine. Therein a central role is assigned to practical know-how 
besides standard clinical and surgical practices and aimed at improving the design and 
use of implantable devices such as the intra-ocular lens [15], the stents for coronary 
artery disease [16] and the Left Ventricular Assist Device-LVAD [20]. What is common 
across these accounts of technical change in medicine is the blending of technical know-
how on the properties of the materials or the mechanic behavior of implantable devices
2
 
with clinical know-how (Figure 1). The latter, in turn, embodies the intertwining of 
                                                          
1
 A paradigmatic case is the pioneering research on glaucoma carried out by Von Graefe in the mid XIX 
Century. He noticed that patients suffering congestive glaucoma experienced remarkable reduction of 
corneal ulceration after the iridectomy, which is a surgical incision aimed at reducing excess pressure 
within the eye. These clinical experiments led Von Graefe to conjecture a causative association between 
the congested appearance of the eye and the hypersecretion of aqueous humor which, eventually, became 
the basis for the Intra Ocular Pressure paradigm, a long-standing clinical framework for glaucoma  
diagnosis and treatment [17:38, 18]. This is a clear instance in which a clinical practice based on the 
explorative assessment of a surgical incision preceded and guided successive scientific inquiry. 
2
 For example, the durability of polyurethanes, of biological compatibility of acrylic glass and of rigidity 
of PVC have been crucial for the development of the LVAD, the intra-ocular lenses and the balloon 
catheter, respectively [20, 15, 16]. 
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clinical (interventional) procedures
3
, viz. surgical approaches, which make device 
implantation physically possible and, more relevant to our case, testing in a clinical 
setting, via experimental trials or regular surgical use, which provides crucial feedback 
about the unpredictable and complex interaction between technology and the human 
body [25].
4
 
This perspective suggest a connection between research on medical innovation and 
particular episodes in the history of engineering brought to the general attention by the 
works of Constant [26] and Vincenti [27]. The bridging concept is that of an 
autonomous professional epistemology, that is, a body of technical know-how not 
subservient or derivative of science. This engineering epistemology
5
 instead blends the 
concept of scientific paradigms by Kuhn [29, 14, 30] with the notion that technological 
knowledge stems from recursive practice in design and testing. The outlined framework 
falls squarely in the variation-selection model of Vincenti [27, 31]: design activities 
spur a variety of solutions in the face of uncertainty about “what works” [32] while 
testing activities act as selection operators. In turn these design-testing dynamics create 
knowledge that is corroborated in practice but need not be necessarily grounded in a 
proven scientific notion [33]. This evolutionary view captures the essence of the 
division of medical know-how (when dealing with implantable devices) between 
                                                          
3
 The National Institute for Health and Clinical Excellence (NICE) defines the ‘interventional procedure’ 
as a “treatment that involves … making a cut or a hole to gain access to the inside of a patient's body”. 
From http://guidance.nice.org.uk/IP , retrieved 29 January 2001. 
4
 In a study on coronary artery disease Mina et al. [16] highlight the pivotal role of the Benestent and 
Stent Restenosis clinical trials of the early 1990s. These provided persuasive evidence of the advantages 
of stenting as opposed to ‘simple’ balloon angioplasty. Similarly Morlacchi and Nelson [20] emphasize a 
multi-center trial carried out in the late 1960s that confirmed the clinical use of Left Ventricular Artificial 
Device in supporting the circulation of patients for longer periods compared to temporary blood pumps. 
In the case of the intraocular lens, Metcalfe et al. [15:1290] underline the clinical studies of the early 
1970s that showed dramatic reduction in time lost by the patient using phaco-emulsification, “the 
technique that transformed cataract surgery”. 
5
 We understand here epistemology in the Popperian sense: “the central problem of epistemology has 
always been and still is the problem of the growth of knowledge” ([28], quoted in [27:17]).  
 6 
 
clinical and design knowledge
6
: design of medical devices is mainly concerned with 
“purely” technological dimensions such as the properties of implantable artifacts while 
testing are crucial to guarantee safety and efficacy in the clinical realm (Figure 1). 
  
- Figure 1 - 
It is important to distinguish between the clinical environment and the particular 
operative conditions of laboratory trials on synthetic or cadaveric models. In the latter 
the complexity of the body-technology relationship is reduced to facilitate development 
activities in a nested variation-selection sub-process [24, 27].
7
 On the other hand the 
“testing regime” [19] of the laboratory environment does not reproduce “real-world” 
selection [32, 33]. Indeed both the FDA and the Notified Bodies of the European 
Commission in Europe mandate that new-to-the-world implantable surgical devices are 
tested clinically on humans – under special experimental exemptions – before approval 
[35]. 
Previous studies about implantable devices deal with the consequences of uncertainty at 
the level of know-what, that is, of scientific understanding of disease. Therein practical 
knowledge is described as unfolding along an almost autonomous trajectory based upon 
the variation-selection model of generation and testing of new device designs with 
minimal guidance from the scientific knowledge of aetiology.
8
 In these instances the 
results from clinical testing play an important role in the evolution of practical ways to 
tackle disease (see footnote 4). The case study of the intervertebral artificial disc 
                                                          
6
 We are grateful to Paul David for pointing this out during a session of the Stanford Science, Technology 
and Society Seminar Series. 
7
 In the nested hierarchy of variation-selection processes a further level is in the “mind experiments” 
carried out by engineers [34]. 
8
 For example, Morlacchi and Nelson [20:512] comment about the intra-ocular lenses case that the 
“breakthrough was not dependent upon any significant improvement in basic understanding of cataracts 
or the workings of the eye”. 
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presented here affords the opportunity to focus on dual uncertainty, not only about 
understanding of disease but also about clinical testing for which there are hitherto no 
univocal performance criteria. This analysis elucidates the emergence of design 
strategies in the process of experimenting with new operational principles when the 
testing part of the variation-selection model is limited by clinical uncertainty. In the 
remainder of the paper it will be argued that hybridization of medical devices is one of 
such strategies. 
 
2.2 – HYBRIDIZATION: EVOLUTIONARY RESPONSE TO UNCERTAINTY 
 
A look at previous literature reveals different postures on hybridization. The first stems 
from a wealth of recent empirical studies on hybrid vehicles. Dijk and Yarime [36] 
associate corporate strategies to different forms of firm behavior such as “pioneer”, 
“slow follower” or “skeptical”; Avadikyan and Llerena [37] elaborate a real options 
approach to study the investment behavior on hybrid cars. Common across these 
contributions is the emphasis on the strategic aspects related to hybridization while little 
attention is paid to the design activities involved in the development of those 
technologies.  
Next to this is a strand of studies that considers the relationships between different 
elements of technological systems.  A classic reference is Sahal’s [38, 39] work on the 
symbiosis between different elements of technological systems such as the 
programmable calculating machine and the solid-state technology of the electronic 
computer. In a similar vein, a study on the Smart House case by Peine [40] elaborates 
on the notion of technological systems as environments where different paradigms can 
 8 
 
coexist, like those associated to information technology and the construction industry. 
Pistorious and Utterback [41:72] add an interesting nuance to the debate by 
conceptualizing different kinds of symbiosis and hinting to a special form of symbiotic 
relationship as ‘hybridization’ – referred, though, not to the relationship between 
complementary elements (like construction and ICTs within a Smart House) but rather 
between competing operational principles that fulfill the same function. Under this 
perspective hybridization is understood as epiphenomenon occurring over the transition 
of technological systems through different paradigms. These transitions take the form of 
niche evolution. Similar hints emerge from accounts of gas turbines portrayed as 
auxiliary device of steam turbines [42], or from studies on navigation technology where 
steam engines are depicted as auxiliary devices for the consolidated sailing ships design 
[43]. In all these cases hybridization is a temporary symbiosis between an incumbent 
technology and a new one, with the latter improving the performance of the former [41].  
At times the new technology further develops within the niche like steamships which 
eventually eliminated sails; other times the symbiotic relationship reverses the 
functional relation like in the case of co-generated power stations where gas turbines 
became the main component and steam turbines the auxiliary device. 
The present study proposes a different view of hybridization not grounded in the niche 
dynamics of technological systems but, rather, connected to the concept of operational 
principles.
9
 The latter, according to Murmann and Frenken [44: 939] facilitate the 
systematization of a set of artifacts into general product classes on the basis of “the kind 
of knowledge a human designer must have in order to build a technological device that 
works on the physical world in a desired way”. It is clear that hybrid technologies have 
                                                          
9
 For example, the principle underpinning human flight proposed by Cawley in 1809 was to “separate lift 
from propulsion by using a fixed wing and propelling it forward with motor power” – put another way, 
moving a rigid surface through resisting air provides the upward force necessary to counter gravitational 
force.  
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hitherto been portrayed mostly as intermediate steps in the process of adjusting existing 
technologies systems to novel emergent criteria through niche evolution [43]. Our 
empirical analysis of the evolution of the artificial intervertebral disk expands on this 
while, at the same time, accounting for functionality and uncertainty. To begin with, we 
argue that technological systems are a special kind of artifacts, complex enough to 
contain different niches. The analysis of hybridization presented here focuses on a 
simple artifact, as opposed to large distributed and multi-component systems such as 
those for transport or electricity, with a view to illustrate the how functionally 
competing operational principles come to coexist outside of traditional frameworks such 
as niche dynamics. Secondly the niche perspective is often associated to energy-
generation systems (e.g. for transport or manufacturing) where “demonstration effects” 
are easier to conceive and measure [45, 46].
10
 In the case of the intervertebral artificial 
disc the absence of clear results about clinical performance implies that hybridization is 
a sound and persistent design strategy. This proposition resonates with Mokyr’s [11] 
suggestion that making “available” different operational principles within a single 
device to minimize and manage uncertainty.
11
 The rationale is: if it works and until new 
problems come to surface jointly adopting several operational principles suffices and 
allows leaving room for future reconfigurations, perhaps after the veal of uncertainty 
has been lifted.
12
 Stated differently, the traditional view of hybridization as temporal 
                                                          
10
 One of such “demonstrations” was a bet about the performance of the first full-scale working railway 
steam locomotive in Pennydarren, in 1804 [47]. Looking at more recent cases, Islas [45:134] mentions 
gas turbines being introduced in the energy system of airplanes as a special application that allowed 35% 
improvements in output power. A related concept in the literature on techno-economic paradigms is the 
“big-bang” at root of long wave developments. Pérez [48] for example claims “big-bangs” coincide with 
demonstrated performance improvements in the application of energy to transport or manufacturing 
activities. 
11
 Mokyr acknowledges that the set of “available” operational principles in the face of changing 
environment is “not a just a set of blueprints that firms and individuals can pick and choose from freely, 
but an underlying knowledge set, far more complex and multidimensional” [11:131]. 
12
 Our concept of hybridization differs slightly from the “availability” concept of Mokyr who uses “junk” 
DNA as an example. DNA contains big parts of “junk” code, in the sense of not having any apparent 
function in the fenotype. But when environmental conditions change these DNA parts turn out to be 
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symbiosis within a niche in conditional logic language would go: “If the new 
operational principle has demonstrated its competence in one element of the system, 
then use it”; in the view proposed here instead hybridization has a more general flavor 
and is functionally biased by uncertainty: “if you do not know which operational 
principle is better, then choose all”.  
 
We believe that this nuanced view of engineering epistemology [12, 49, 40] overcomes 
narrow interpretations of the concept of technological paradigm. In fact rather than 
accepting incommensurability of competing principles along the canonical terms 
suggested by Kuhn [14] our view highlights the potential benefits stemming from the 
combination of different approaches to know-how towards a single solution, a medical 
device in this case. Thus contrasting Kuhn we suggest that “proponents of competing 
paradigms may practice their trades in the” same world [14: 150]. The evolutionary 
nature of this particular technical solution resonates with Stark´s [50: 164] insight on the 
generative role of diversity whereby “rivaling performance criteria […] contribute[s] to 
adaptability by preserving a more diverse organizational gene pool”.13 Let us now frame 
the analysis of hybridization in the case of the artificial disc. 
 
3. UNCERTAINTY AND THE ARTIFICIAL DISC 
In section 2.1 we sketched the contours of a framework where variation in design was a 
response to uncertainty. This section illustrates how in the case of artificial disc 
                                                                                                                                                                          
“useful”: “The human gene uses only about 1 percent of the DNA; the rest seems to fulfill no obvious 
function, but changes in it may at some point in the future become useful” [11:123, note 7]. In the view 
presented here the operational principles joined in the hybrid device are seen as having more than purely 
random possibilities of success. 
13
 We thank an anonymous referee for calling our attention to this work. 
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uncertainty refers not only to fundamental know-what about disease but also to know-
how on clinical testing that is essential for the selection of the devices. 
The appearance of the artificial disc in spinal surgery marks a significant step of 
scientific, social and economic importance in modern medicine. This prosthesis device 
is implanted in the spine to treat Degenerative disc disease (DDD), a physiological 
affection of the discs between vertebrae. The latter is recognized as the main cause of 
back pain and disability among adults in the United States whose associated costs have 
been estimated around £ 1.6bn in the UK [51] and $26 billion in the US [52].
14
 
After an experimental phase in the late 1960s a surgical  technique to implant the 
artificial disk appeared in Europe around the late 1980s under the name of arthroplasty. 
This became an alternative to arthrodesis, or osseous fusion – the gold standard for the 
treatment of DDD consisting in the replacement of the disc with an osseous bridge 
between adjacent vertebrae (Figure 2).
15
 Though not yet at a mature stage the market for 
artificial discs has experienced considerable growth and is estimated to reach 3 billion 
dollars volume and to progressively overtake arthrodesis as standard clinical practice 
[54, 55]. 
 
- Insert Figure 2 around here. 
 
                                                          
14
 The significance of DDD is well outlined in an editorial by Weiner [53:474]: “Despite the significant 
improvements in the treatment of many pathologic processes witnessed over the past century, some 
particularly difficult medical problems persist. These problems are characterized by unclear underlying 
etiologies and less than desirable outcomes of treatment in the face of considerable intellectual and 
financial investment. Examples include (…) degenerative disc disease. This latter problem (…) is 
particularly important given the societal repercussions – disability, work absenteeism, and health care 
costs (in the billions of dollars) associated with it are considered at ‘crisis’ level.” 
15
 The physiology of DDD in the lumbar and the cervical area are very similar, and so are the prostheses. 
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A look at the specialized scholarly literature suggests wide diversity of views about the 
nature and the pathogenesis of DDD [56].
16
 There is a kinematic theory strongly 
focused on the movements of the spinal disc which does not take into account the forces 
that produce the motion. On the other hand there is a dynamic theory that is mostly 
concerned with the combined effect of motion and loads.
17
 According to the former, 
back pain is a consequence of abnormal movements in the disc affected by DDD, and 
artificial disc replacement restores normal mobility [57]. According to the latter theory 
the dynamic properties of the anatomic disc, and specifically the load absorption of the 
cartilaginous articulation, play a crucial role in triggering the disease. To mimic 
anatomic load absorption, this theory goes, the artificial disc should reproduce the 
viscoelastic properties of a healthy disc. Both kinematic and dynamic theories about the 
sources of back pain signal intervertebral fusion or arthrodesis as an inappropriate 
surgical treatment for DDD, as they argue that the rigid nature of the bone bridge may 
trigger biomechanical alterations which ultimately can cause degeneration in the 
adjacent discs (the so-called ‘adjacent disc degeneration syndrome’) and the need for 
further surgery [58]. 
Although early hints at the dynamic aspect of disc functionality date back to the early 
1970s [59], uncertainty persists about the actual importance of load absorption. 
Difficulties in measuring load absorption both in vivo and in laboratory environments 
are the main cause of chronic paucity of data about the properties of the intervertebral 
disc [60:347]. To the best of our knowledge, only one laboratory study set out to 
                                                          
16
 Besides the biomechanical explanation a purely chemical explanation refers to the pain-provoking 
chemical changes of the discs during the degeneration process [56]. 
17
 An extreme version of this has been proposed by Mulholand [57], namely that loads are the only 
biomechanical cause of pain in the disc, and that movement related causes are “a myth” that has 
dominated spinal biomechanics for the last 30 years.  
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analyze the impact of load absorption by means of invasive force sensors installed in a 
cadaveric model of spine units [61]
18
. 
Deficient knowledge on the workings of the natural disk affects also the design of the 
artificial device that is supposed to replace it. The history of DDD treatment is in fact a 
tale of how this uncertainty has become a focusing device for designing a clinical 
solution. The first artificial disk to be adopted for clinical use was built on what we refer 
to as ‘hip-like’ operational principle, a ball-and-socket mechanism developed originally 
for hip prostheses by Sir John Charnley in the 1960s [62]. The principle underlying this 
device, substituting the hip articulation with a prosthetic implant, is one of the most 
successful surgical inventions of recent times as confirm the widespread adoption for 
the treatment of other articulations, such as knee and shoulder
19
. These developments 
were pivotal in bolstering both orthopaedic surgery and the implants industry [64]. The 
SB Charité hip-like artificial disc for the spine was the first to be commercialized in 
1987 in Europe and, after 2004, in the US. These artificial discs feature rigid contact 
surfaces in the form of a ball-and-socket articulation made of material akin that of hip 
prostheses, i.e. metal or relatively rigid plastic such as UHMWPE (Figure 3). Although 
these discs enhance mobility of the intervertebral segment, their rigid surfaces prevent 
effective load absorption [60]. 
 
- Insert Figure 3. 
                                                          
18
 In the words of an artificial disc designer: “You cannot put a sensor in an in vivo environment to 
measure load absorption. And that means that, at best, you can only have in vitro data for this property in 
the healthy, degenerated and artificial disc. And you cannot trust only in -vitro data since these are highly 
dependent on the specific design of the laboratory experiment”. Furthermore, laboratory experiments 
simply cannot reproduce some conditions of the in vivo environment: “The dynamic load-response 
behavior of the anatomic disc could depend even of the hour of the day, and you cannot reproduce that 
with cadaveric specimens”. This stresses the crucial importance of clinical testing in the variation-
selection process of adoption of new designs of implantable devices, pointed in Section 2.1 of this paper. 
19
 This “lineage development” [63] of a technology outside its original domain of application is typical of 
technological evolution. We thank an anonymous referee for pointing this out. 
 14 
 
 
The alternative operational principle to ‘hip-like’ is the ‘mimetic’, adopted first in 
Europe in 2007 while still awaiting approval in the US. Although mimetic discs are late 
entrants in clinical use numerous R&D projects contributed to perfect this operational 
principle especially in the US [65]. Mimetic-type artificial discs are designed to 
replicate the articulation of the anatomical disc not only for what concerns movement 
but also for load absorption (Figure 4). As anticipated earlier however since the 
effective impact of load absorption for both natural and artificial discs has not been 
established with certainty, opinions concerning these operational principles go both 
ways. Advocates of the hip-like disc maintain that the absorption of load in the 
anatomical disc (if it exists) is irrelevant and that prosthetic restoration of movement 
suffices [66]. Conversely advocates of the mimetic disc argue that disregarding load 
absorption generates biomechanical problems and painful symptoms that often end up 
with further surgery [58].  
 
- Insert Figure 4 
 
Besides this basic uncertainty concerning load absorption, there is also a fundamental 
uncertainty about the differential clinical performance of the mimetic and the hip-like 
discs. To the best of our knowledge, no clinical or laboratory study of any type has so 
far been set to compare the performance of the two principles of artificial disc. This is 
possibly because specialists are preoccupied by an even bigger task, that is, proving the 
efficacy and safety of the whole artificial disc rationale compared with the surgical gold 
standard of arthrodesis, or bone fusion of two vertebrae through the intervertebral space 
 15 
 
(see Figure 1). This task has been proved difficult: in the randomized studies carried out 
so far and, although disability and quality of life scores tip in favor of arthroplasty, no 
evidence can be said to support conclusively either procedure.
20
 
 
Thus, there are two fundamental uncertainties derived from testing. The first stems from 
the difficulty of measuring load absorption in the disc – be it healthy, diseased or 
artificial. And, second, a lack of tests aimed at measuring the comparative performance 
of different operational principles of disc prosthesis. The contested terrain here is the 
comparison with arthrodesis which continues to attract resources and attention.  
In our view these two fundamental uncertainties triggered different responses 
concerning the variety of artificial designs. The first response paved the way to the 
mimetic/hip-like variants, since uncertainty about the concrete amount of load 
absorption stands behind the decision to either incorporate this property in the device 
configuration (mimetic) or not (hip-like design). The second response adds the hybrid 
design to the mimetic/hip-like repertoire, and relates to testing uncertainty about the 
clinical differential performance of these two competing principles. In next section we 
propose this uncertainty is crucial in the rationale of the hybrid design. 
 
4. HYBRIDIZATION AND THE ARTIFICIAL DISC 
4.1 – A case study about the hybrid disc  
                                                          
20
 In its evidence-based guidance for the use of the artificial disc of both 2009 and 2010, the National 
Institute for Health and Clinical Excellence (NICE) identifies 5 randomized controlled trials comparing 
the efficacy of artificial disc and fusion. In 4 of 5 of these studies the differences were non-significant at 
the end of the follow-up. This circumstance affected the launch of the artificial disc in US in 2005, where 
many insurance companies, as well as Medicare and Medicaid, initially authorized only very limited or no 
reimbursement at all for performing the procedure in the United States “due to the lack of good evidence 
of long-term clinical benefit and safety” [67:329] even after the FDA approved trials. Although 
reimbursement of artificial disc is now broader, this issue is still one of the most important hurdles in the 
adoption of this technology in US. 
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This section outlines the basic design principles and the steps that led to the definition 
of the Bryan artificial disc, the only hybrid device that has been approved for clinical 
use.
21
 Let us begin by noting that the dualism between the hip-like and mimetic 
operational principles is a recurrent theme in the specialized medical literature. A 
survey article by Bono and Garfin [56] refers to ‘articulated non-elastic discs’ and 
‘elastic discs (with load absorption)’. Also Lee and Goel [58] mention ‘kinematic discs’ 
and ‘kinematic and absorption of load discs’ while Szpalski et al. [65] talk about 
‘artifacts destined to restore the kinematic functions’ and ‘… to restore the viscoelastic 
functions’ respectively. Interestingly only the latter study acknowledges that the history 
of the artificial disc features ‘some devices [that] attempt to combine both principles’ 
[65:S67]. Hints at hybridization can be found also in patent n. US5314477 that mentions 
the possibility of a “combination of these two research routes” in the design of the 
artificial disc, and in patent n. US7563286 whose classification of disk devices includes 
a hybrid category with different design principles. 
To appreciate the hybridization trajectory we take a look at the circumstances 
underpinning the development of the Bryan artificial disc. The clinical origins of this 
venture are mentioned in a published interview with Dr. Bryan, a spine surgeon [68]: 
“In North West there is a very young population which is very active in outdoor 
activities, whether mountain climbing, topping trees, fishing and so on. Many young 
people present to us with … early degenerative changes in their spine and get operated 
with the usual operating procedure. Then these people are coming to us after 5/6 years 
and in a significant number of them, we find ourselves re-operating… So I have been 
                                                          
21
 The technical specifications presented here have been validated through interviews with four experts. 
One of them was involved in the development of the Bryan disc in late 1990s; another was involved as a 
design engineer in one of the most important mimetic projects of the late 1980s, the Acroflex artificial 
disc. The other experts are R&D engineers currently working in new artificial disc developments, one 
hip-like and the other mimetic. 
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thinking of this for many years”. Seeking engineering advice, Bryan joined forces with 
Alex Kuntzle, a mechanical engineer from the metallurgic industry. After a patent 
application in 1994 they sought venture capital to fund Spinal Dynamics a start-up to 
develop a spinal disk device. The company was subsequently acquired by Medtronic 
Sofamor Danek (MSD) for 269.5 million US dollars at the beginning of the 2000s. The 
Bryan disc received approval for clinical use for Europe in 2001 and in 2009 for the US 
[69, 70]. It has been estimated that up to 2010 the Bryan disc has been used in about 
35000 surgeries. 
The thrust of this venture, Dr. Bryan claimed, was seeking “to change the nature of the 
joint from an arthrodial joint to restore something similar to diarthrodial joint” [68:8].22 
While this statement refers to a hip-like principle, Dr. Bryan also claims that the 
artificial disc should provide “cushion as the normal vertebral disc” [68:8], the latter 
being a distinctive property of mimetic design. To confirm this, patent No. US7025787 
(by Bryan, Kuntzler et al owned by Medtronic) claims that the implant “should also 
provide elasticity and damping sufficient to absorb shocks and stresses imposed on it in 
a manner similar to that of the natural disc”.23 Patent No. 7025787 (2002) presents the 
salient features of the Bryan artificial hybrid device: one elastomer
24
 and two small 
metal plates that act as disc-bone interface to ensure stability. These specifications 
suggest close similarity with the mimetic Acroflex disc (Patent No. US5071437) (see 
left-hand side of Figure 5) the outcome of an important venture in the orthopaedic 
implants industry in the1980s.  
 
                                                          
22
 Diarthrodial joints (or synovial joints), such as hip or knee, joints are freely moveable; Arthrodial joints 
(or cartilaginous joint), as the spinal disc, only allow for limited movements. 
23
 In this patent also is stated that the goal of the invention is to transform a natural arthrodial joint like the 
spinal disc in an artificial diarthrodial joint.  
24
 Elastomer refers to materials with mechanical properties (e.g. hysteresis) similar to rubber.  
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- Insert Figure 5. 
 
Early tests of this device highlighted both in the laboratory and in human trials repeated 
failures of the elastomer, the component that is expected to provide load absorption and 
motion [65, 67]. This occurrence proved crucial for the conception of the Bryan Disc 
whose layout features an important variation compared to the basic mimetic 
configuration: the small plates are allowed to rotate around the elastomer thus creating a 
ball-and-socket articulation similar to hip-like discs (Figure 5, right-hand side). The 
mimetic operational principle instead features small plates joined to the elastomers, in a 
‘sandwich configuration’ that does not allow rotation (Figure 5, left-hand side). The 
existence of elements of both operational principles in the design of the Bryan disc is 
also signalled by the citations of US -the first patent associated to the Bryan disc- which 
include both mimetic (as US4911718) and hip-like (DE3023353) patented designs. 
The Bryan disc, it is worth stressing, was conceived against the backdrop of a debate 
about the performance of the sandwich configuration of the mimetic principle and the 
initial positive performance of the hip-like device. As a matter of fact, hip-like disks 
gained momentum in the early 1990s after diffusion of negative results of experimental 
clinical trials with the Acroflex disc [71] and of positive feedback from non-randomized 
trials of the SB Charité disc – a lumbar hip-like design [72].25 Shortly afterwards the 
Frenchay hospital in Bristol, UK, one of the most prestigious centres in the world for 
                                                          
25
 There are institutional differences between the clinical results coming from Acroflex and SB Charite’s 
first human implantations in the late 1980s. The former project was carried out by Acromed an US-based 
company which applied for a special IDE (Investigation Device Exemption) required by FDA to conduct 
experimental clinical trials on humans. SB Charité – developed by Waldemar Link, a German company – 
was implanted before the 1993 European regulation requiring similar trials for new devices [35]. The 
results reported in the early 1990s for SB Charité do not come from official experimental trials but from 
regular clinical use in Germany, Netherlands and France. In 2000, Waldemar Link started the FDA trials 
required for the regular implantation of SB Charité in US. In any case, both in the hip-like and mimetic 
designs results of the early 1990s involved human clinical testing, which is the selection part of the 
variation-selection process of new device emergence we are interested in. 
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neck surgery announced positive experimental results on humans with a cervical hip-
like prosthesis [73]. 
 
- Insert Figure 6 around here. 
 
Let us offer a functional analysis of the technical aspects involved in the evolution of 
the hybrid disk. Figure 7 represents the design trajectories of hip-like, mimetic and 
hybrid principles. To highlight design characteristics we refer to what Ulrich [74] calls 
the “iota level”, viz. the individual pieces. 
 
- Insert Figure 7 around here (figure 7 at the end of the paper). 
 
Early prototypes of the artificial disk featured steel (Fenström; Reitz and Joubert) or 
silicone spheres (Nachemson; Fassio and Ginestie) aimed at improving mobility and 
load absorption (the silicone spheres) or mobility only (the stainless steel devices). It 
soon became clear that the spheres were not suited to reproduce the properties of 
cylindrical discs in supporting adjacent vertebrae (Figure 8). Bono and Garfin [56:147S] 
distinctively refer to those failures as lessons learned for future developments. One 
route in this problem sequence entailed the addition of two intervertebral plates between 
the ball and the adjacent vertebrae to improve stability [56; 54].
26
 In this second 
generation of hip-like artificial discs the ball-and-socket articulation is the component 
that affords mobility to the intervertebral space. In Figure 7, the ‘SB Charité’ and 
                                                          
26
 The addition of components to overcome the limitations of primitive and crude original prototypes is a 
typical phenomenon of early phases of technical invention. Arthur [75] describes it as “structural 
deepening”. 
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‘ProDisc’ labels in the upper part coincide with the most representative designs among 
hip-like artificial discs. Subsequently additional problems guided the incremental 
transformation of the design to improve the performance of the ball-and-socket 
articulation (‘Prestige’ and ‘Maverick’ labels in upper part of Figure 7). In the mimetic 
principle (bottom part of Figure 7) two additional plates were attached to an 
intermediate elastomer to create the sandwich configuration that provides both mobility 
and load absorption. But the elastic layer impairs the stability of the implant, as 
demonstrated by repeated and unexpected failures in clinical testing of the Acroflex 
disc
27
 which was followed by general distrust on this configuration. As mentioned 
earlier the mimetic design has the elastomer and the plate joined in the same mould, a 
feature that disregards relative rotation. This constraint creates excessive load on the 
elastomer with the risk of structural failure of the device [76]. The hybrid model 
appeared in the mid-1990s (central part of Figure 7) joins the ball-and-socket and the 
elastomer elements in a single device, thus providing mobility and load absorption like 
the mimetic principle but in a different way, since the vertebral plates are not joined to 
the elastomer but articulated in a ball-and-socket joint. As a result the mimetic kind of 
failure of the elastomer is overcome by the hybrid design of the Bryan Disc.
28
 
 
- Insert Figure 8. 
                                                          
27
 The failures of the Acroflex were repeated as this device was tested in humans in three cohorts, in 
1988-1989, 1993-1994 and 1998-2000 [67]. They were unexpected “given that the device was extensively 
tested in the laboratory and had easily withstood the range of described normal in vivo loads on the … 
intervertebral disc” [76:248S]. This again (see footnote 18) stresses empirically the differences between 
laboratory and human clinical testing we assume in Section 2.1 variation-selection model.  
28
 The mimetic principle experienced a renaissance with 3 designs recently adopted for clinical use in 
Europe after 2008, and currently under analysis with experimental clinical tests for adoption in the US. 
[77]. This revival is due to the introduction of additives (polycarbonates) in the elastomers, a modification 
that seeks to improve the mechanical performance of elastomers and minimize the effect of the load 
constraints of the sandwich configuration (designs ‘M6’ and ‘Freedom’ in the lower-right corner of 
Figure 7). 
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The hybridization of the artificial disk entailed a number of incremental ameliorative 
efforts. Part 70 in Figure 6 indicates a membrane attached to vertebral plates whose 
function is preventing migration of plastic particles from the hip-like articulation. The 
latter was a key salient since the particles provoked allergic reactions and resulted in 
systematic failure of hip implants. The adoption of special plastic support (UHMWPE) 
addressed this particular problem and consolidated hip substitution into one of the most 
successful surgical procedures worldwide. At the same time UHMWPE is a rigid plastic 
incapable of providing significant load absorption [60]. To accommodate this operating 
principle the Bryan hybrid design needed a more elastic material. Polyurethane, one 
candidate, raised concerns about the biocompatibility of the particles which were 
expected to provoke negative response compared to UHMWPE [78]. The Bryan design 
was eventually further modified by the inclusion of an isolating membrane that avoids 
the deleterious effect of polyurethane (Figure 9). Clearly the extra design efforts entail a 
growth in the complexity of the device, a familiar characteristic of hybridization 
according to other studies such as for example the hybrid car [36]. 
 
- Insert Figure 9 around here. 
 
 
The Bryan disc hit the European market in 2001
29
 followed shortly afterwards by a 
number of hip-like discs. Sales data reported by Biondo and Lown [69] show that in 
                                                          
29
 Artificial discs are used both in lumbar and cervical surgery. Although the size of the artifacts depends 
on the spinal area the patented designs usually refer to the spinal zone, with no distinction between 
cervical and lumbar prosthesis. In general the development of disc prostheses depends strongly on the 
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2004 the Bryan disc dominated 2/3 of the cervical disc market (2500 surgeries), while 
1/3 was the share of the remaining 3 hip-like designs (1300)
30
. Figure 10 illustrates the 
sales volume of artificial discs worldwide between 2000 and 2004 [69]. It is estimated 
that so far as many as 35000 surgeries have been performed to implant the Bryan Disc, 
mostly in Europe. Although no data about production costs are available it is reasonable 
to expect that the Bryan hybrid device was no cheaper than hip-like disks. Indeed the 
preceding paragraphs suggest the complexity of the Bryan Disc whose design entails 
more components and assemblies compared to the “good old” technologies [79:2] based 
on the articulation concept of the hip prosthesis [62]. This resonates with the 
observation that surgeons are the ultimate decision makers and are strongly oriented by 
product quality. As Lieberman [54:610] points out, in the spinal implants market “price 
has become a secondary determinant of demand, only remotely involved because 
physicians, who function as the principle users, are not the typical final consumer”. 
 
- Insert Figure 10 around here. 
 
Let us sum up the technical configurations outlined this far. As the introductory section 
spells out hybridization is a design strategy aimed at making efficiently “available” all 
the operational principles that can be useful to confront the existing lack of comparative 
performance testing (as we have seen in Section 3) by bundling them together in a 
single artifact. As seen above, the hybrid Bryan device incorporates the known positive 
characteristics of the hip-like disc with the additional potential advantage of catering for 
                                                                                                                                                                          
capabilities of the surgeons involved. Bryan, for example, was mainly concerned with the cervical region. 
At the same time the technological principles of the Bryan disc are applicable both to the cervical and 
lumbar regions: in the patents the artifact is referred to as a “spinal disc endoprosthesis”, with no 
specifications of the anatomic region involved. 
30
 The Bryan disc was the second in a list of 9 lumbar/cervical artificial discs sold worldwide, only below 
the lumbar SB Charité, a hip-like design.  
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load absorption. Table 1 compares synthetically the advantages and the disadvantages of 
the three principles discussed so far. 
  
- Insert Table 1 around here. 
 
4.2 Hybridization through time 
This section illustrates the unfolding and co-existence of multiple trajectories in 
artificial disk technology. We implement connectivity analysis on patent citations data 
[16, 80, 81, 82, 83].
31
 These were collected by means of keyword search
32
 from the 
USPTO database for patents granted until 2008. This returned 201 items which were 
subsequently parsed to extract cross-patent citations. We added citations to patents of 
other kinds of medical products to study the technological antecedents of the selected 
products [16]. Our final database includes 1535 patents and 6130 citations. The 
algorithm “Network of the Evolution of the Top Paths” (proposed by Verspagen [81] 
and applied in [83] and [82]) is used to gather citation sequences among the most 
important patents on the artificial disc which form the top path (labeled with red color in 
Figures 12, 13 and 14). We consider important patents those that result in a product that 
is in use. The top path contains a higher proportion of those patented developments, 
leaving the other branches (labeled with yellow color) to be dead-ends where 
                                                          
31
 We use US patents for our artificial disc search as they are the only ones used in connectivity analysis 
so far. This geographical bias has to be acknowledged), since Europe played an important role in the 
history of the artificial disc. We tried to capture the influence of European developments in our history of 
the artificial disc. However, the large majority of US’ patent shares (160 of the 201) for artificial disc 
seem to belong to a seemingly ‘autonomous’ trajectory. These 160 patents belong to patent families 
associated to a US priority date or to a WIPO priority date applied first in North America.  Also, 112 of 
these 160 patents have European ‘offspring’ indicating that invention activity in the US has been 
influential in Europe while there is no reciprocity in this influence: of the original 201 patents only 41 
have an ex-US origin [84]. 
32
Key words searched in the title and the abstract of the patents: “disc prosthesis”, ‟ artificial disc” and 
“arthroplasty”. 
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technology did not advance [81,83]. Figure 11 offers a synthetic summary of the growth 
of the three operational principles in the network, and depicts the temporal evolution of 
the 53 patents that make up the “network of the evolution of the top paths” algorithm 
shown in Figures 12, 13 and 14. Details of the corroborated validity of connectivity 
analysis applied to artificial disc patents are provided in Barberá et al. [84]. 
 
- Insert Figure 11 around here. 
 
Looking at the citation network three patent groups stand out: hip-like (squares), 
mimetic (circles) or hybrid (triangles). We previously mentioned that the first phase of 
the evolution of the artificial disc in the US (1973-1987, that is, prior to market 
introduction of the hip-like SB Charité, in Europe) was based on a mimetic design 
principle, labeled with red circles in Figure 12, which were important for early 
laboratory feedback about the simulation of the surgical procedure to hip-like 
developers. As anticipated above negative trial outcomes eventually led to the 
abandonment of mimetic disc projects. In the meantime as early positive outcomes of 
the hip-like operational principle were being published in Europe, US-based companies 
intensified efforts towards hip-like devices such as the Maverick Disc or the Prestige 
Disc. This change of direction can be observed in Figure 14 where the trajectory of the 
US top path diverts from mimetic to hip-like operational principle (red square patents) 
that dominates the top path after 1998. 
Dead-end patents (yellow dots) in Figure 13 are included to illustrate the extent of trial-
and-error during the period 1987-1997. Among these we note mimetic designs (yellow 
circle patents), hip-like designs (yellow square patents) and some hybrid configurations 
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– the three yellow triangles enclosed by a blue dotted circle at the bottom of the figure. 
More specifically, patent No. US5674296 is the first associated to the Bryan disc project 
while US6001130 and US6156067 are continuations-in-part.
33
 Figure 14 shows that this 
exploration in the hybrid terrain does not continue in the top path and turns towards hip-
like patents after 1997.
34
 Hybrid designs continue to flourish in the 1997-2004 phase but 
not in the top path. The figure indicates also various hybrid patents around the top path 
(enclosed in blue dotted ellipses) belonging to three
35
 hybrid development projects (like 
in the Bryan patents, there were several continuations-in-part, so the 1997-2004 stage 
features more hybrid patents than hybrid projects). 
 
- Insert Figure 12, 13 and 14 around here. 
 
The analysis presented here illustrates the transition of inventive activity that led to the 
definition of the Bryan hybrid disk in the mid-1990s. This device emerged in a context 
dominated by the mimetic design between late 1980s and early 1990s and by hip-like 
design in the 1990s. It is worth stressing two important circumstances. It is important to 
clarify that this analysis is limited to inventive activity in the US since European 
developers traditionally favored devices based on the hip-like principle. Furthermore the 
present analysis focuses on the 1973-2004 period, indeed an intense one but certainly 
not the last chapter of the artificial disc technology – or several others for that matter. 
                                                          
33
 Continuations permit an applicant to refill a pending patent application. Continuations-in-part are 
special kind of continuations which includes a substantial portion or all of the parent application and adds 
matter not disclosed in that application, although the benefit of early priority is awarded only for the 
original disclosures contained in the new application [85]. 
34
 The position of the last two hybrid patents in Fig. 11 is due to truncation of the patent data in the last 
years [81] and do not necessarily mean a shift in the importance of hybrid designs. 
35
 One of these projects was finally approved for clinical use as a hip-like design. We include it in the 
hybrid operational principle because the patents associated to the project include, apart from the hip-like 
realization, other designs to include a load absorption effect. 
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The mandatory note of caution therefore is that the technological trajectory under 
analysis is still unfolding and turns and further twists are a possibility.
36
 To be sure over 
the last three years there has been a recent renaissance of mimetic designs that have 
been adopted in Europe and are under pre-approval trials in the US (see footnote 28 and 
lower-right corner of Figure 7). This circumstance is not reflected in our citations map, 
and it raises new thoughts about the adaptability of the hybrid discs: if the mimetic 
renaissance finally confirms the clinical superiority of this operational principle, it is 
reasonable to suppose that the hybrid disc is well-equipped to face the new situation, as 
its configuration presumably allows load absorption.  
 
Transition perspectives sometimes concede little strategic value to hybridization. 
Utterback [86:191], for example, states that “bridging a technological discontinuity by 
having one foot in the past and the other in the future may be a viable solution in short 
run, but the potential success of hybrid strategies is diluted from the outset compared to 
rivals with a single focus”. Therefore viewed from the perspective of mid-1990s state-
of-the-art among US specialists the “past” of artificial disk exploration consisted of a 
series of failed attempts within the mimetic logic while the “future” pointed at the hip-
like design, while nowadays the favor seems to have tipped again for the mimetic 
principle. The essentially adaptive character of hybridization restates its value under 
radical uncertainty. Such a perspective resonates with nuanced views of technological 
expectations that account for the strategic value of other real, common and ‘rational’ 
alternatives and that differ from the inevitability of embracing new technologies during 
technological transitions [87]. As Rosenberg [88] argued long ago, when the speed of 
technological change is high and some future major innovations are deemed plausible, 
                                                          
36
 We thank an anonymous referee for stimulating a thorough reflection on this point. 
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the diffusion rate of the present new technology is delayed since adopters would rather 
wait for future improvements rather than being locked-in within a design that may soon 
turn out to be obsolete or inferior. Accordingly, the case study of the artificial disc 
suggests that persistent and radical uncertainty on the nature of disease poses serious 
limitations to the stability of design standards given that any new discovery may 
undermine the attendant logic of therapy. In such circumstances hybridization is a sound 
strategic response and not just a conservative option whose potential success 
(paraphrasing Utterback [86:191]) “is diluted from the outset compared to rivals with a 
single focus”. This is reflected also in the historical excursus presented above and, in 
particular, the circumstances behind the adoption of the hybrid artificial design among 
US developers in the early 2000s (see triangles enclosed by two blue dotted circles in 
Figure 14, also represented by the labels US7022139, US7067959 in the mid-right part 
of Figure 7).  If indeed the recent renaissance of the mimetic disc driven by the arrival 
of new biomaterials (see footnote 28) holds sway and load absorption design turns out 
to be the ultimate “winner” in this ongoing battle , hybrid designs of the mid-2000s, 
which comprise components theoretically capable of absorbing load (labels 
US7022139, US7067959 in Figure 7), will likely be fitter to the new configuration 
compared to the contemporary hip-like artificial discs (labels ‘Prestige’ and ‘Maverick’ 
in Figure 7) with no absorption capacity. 
 
5. DISCUSSION AND CONCLUDING REMARKS 
This paper adds to the growing body of work on health technologies that received much 
attention among innovation scholars in recent times. The case studied here, the artificial 
disk, illustrates the extent to which design heuristics contribute to devising a remedy to 
a practical problem, back pain, in the absence of definitive knowledge on the nature of 
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the cause (Degenerative Disk Disease) and on the comparative performance of the 
devices designed to alleviate its painful effects. Our analysis shows that search within a 
novel design space under the penumbra of imperfect understanding led to the 
proliferation of competing standards. Far from being the mark of a settled issue the 
recently-emerged artificial hybrid disk is a satisficing [89] solution to minimize the 
impact of the apparition of new therapeutic goals that may, or may not, come to surface 
once the veil of ignorance – concerning the disease and the clinical performance of the 
devices – is lifted. Hybridization of medical device therefore is the visible face of an 
inter-temporal externality between state-of-the-art and knowledge that is not totally 
proven but whose future discovery can be presumed [90]. Consistent with Mokyr’s [11] 
claim that making available different operational principles mitigates the disruptive 
consequences of uncertainty, the prevailing rationale in disk surgery replacement has 
become: “If you do not know which operational principle is better, then choose all”. 
The present study argues that hybridization is an evolutionary strategy in the 
implementation of design solutions to ill-specified health problems. It is evolutionary in 
the sense that variety is generated in the face of uncertainty [91]. The prevailing body of 
practice is therefore understood as a dynamic learning process feeding on and bearing 
upon the broad knowledge bases that make up medical communities wherein operate 
scientists, practitioners, engineers as well as managers and policy makers [21]. Looking 
at this process through the lenses of history reveals that the long-term trajectory of 
medical innovation does not resemble a punctuated succession of alternative paradigms 
but rather an incremental inter-penetration of different problem-solving styles wherein 
emergent courses co-exist with, rather than abruptly replacing, old ones [92]. To 
reiterate, this trajectory emerges as purposeful response to absence of conclusive 
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indications on the nature of disease and consists in balancing “mutually coevolving yet 
not converging paths” [50: p. 26]. 
These issues carry broad relevance for the divide that exists in the problem spaces of 
medical science and practical knowledge. In the case at hand alleviating back pain 
entails, in principle, knowing the nature of the degenerative process in the spinal disk 
and devising a technique to reduce the physical discomfort that it causes. This unity of 
intents however subsides against practical reality. Medical know-what pursues general 
understanding of the neurochemical and physical properties of disk degeneration while 
clinical and design knowledge seek to develop useful artifacts and a set of stable 
routines. As patterns of specialization, research styles and professional goals deepen, 
‘learning what disease is’ and ‘learning how to tackle disease’ unfold along distinct 
problem-solving trajectories. The necessity of offering a clinical response to an ill-
understood disease induces forms of knowledge organization based on practical and 
identifiable problems rather than general chemical or biological principles. 
Dynamics of this kind, Nelson [7] argues, place medical knowledge in the vicinity of 
engineering science more than had hitherto been realized and suggests careful reflection 
about the terms in which scholarly and policy discourses are couched. The foregoing 
analysis elucidates on purportedly complementary and yet perpetually parted domains 
of descriptive and prescriptive knowledge, the former indicating things as they are the 
latter how they should be to attain a desired goal [27]. Descriptive knowledge is 
assessed in terms of correctness, prescriptive knowledge in terms of degrees of success 
or failure; but contrary to descriptive knowledge, prescriptive knowledge is open to 
deliberate adaptations to a prescribed end. By the same token, errors, unintended 
variations and unexpected consequences play a strong role in the progress of medicine. 
A key prerequisite to harness these lessons and overcome translational gaps, that is, 
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bottlenecks that impede effective feedbacks between scientific, clinical and 
technological knowledge is the existence of institutional channels for facilitating the 
transmission of feedbacks. A great deal of hope about broadening the horizons of 
medicine rests in the prospect that these epistemological terrains may be effectively 
bridged. 
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Figure 1. Typology of medical knowledge about implantable devices. 
 
 
 
 
 
 
Figure 2: On the left, the fused vertebrae in an arthrodesis. On the center, the 
degenerated disc is replaced by a prosthesis. Source: US3867728 
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Figure 3. On the left, a hip prosthesis. On the right, a disc prosthesis following the ‘ball-
and-socket’ principle of hip implants (Source: US6986792 and US5755796).  
-  
 
 
 
 
 
 
 
Figure 4. The diagram on the left shows an anatomic intervertebral disc. The diagram in 
the center shows a “mimetic design” based on the reproduction of the viscoelastic 
properties of the anatomical disc, using materials such as synthetic elastomers (Source:  
US6610094). 
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Figure 5. To the left, a classic elastomer/vertebral plates configuration of a mimetic 
patent related with the Acroflex project; to the right, a typical hip-like configuration 
(Source: US5071437).  
 
 
 
 
 
 
 
Figure 6. (Source: US7025787).  Element 99 function is to absorb load, as in mimetic 
operational principle patents. However, instead of being joined to small plates 20 and 
40, they move over them, as in hip-like patents. Element 70 is a membrane designed to 
avoid migration of particles from the movement of the articulation between 99 and 20-
40. 
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Figure 8. A radiography of a Fernstrom ball 3 years after surgery. The steel ball has 
become encrusted in the bones because of the high pressure exerted in the original one-
point contact between vertebrae and ball (source: [56]). 
 
 
 
 
 
 
Figure 9. The Bryan artificial disc. Only the metallic vertebral plates and the external 
membrane can be seen . 
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Figure 10. Sales evolution (in units sold) of artificial discs in 2000-2004. Source: own 
elaboration from data in [69]. 
 
 
 
 
 
 
 
 
Figure 11. Number of granted patent of mimetic, hip-like and hybrid patents in the 
Network of the Evolution of Top Paths. 
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Figure 12: The Network of the Evolution of Top Paths (NETP) 1973-1987 
 
 
 
 
 
 
 
 
 
 
Figure 13: The Network of the Evolution of Top Paths (NETP) 1973-1997 
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Figure 14: The Network of the Evolution of Top Paths (NETP) 1973-2004 
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Design 
elements 
Services Comparative 
advantages 
Comparative 
disadvantages 
Mimetic 
Sandwich 
configuration, 
with a 
constrained 
elstomer. 
Motion and a 
presumable 
amount of load 
absorption. 
A presumable 
amount of load 
absorption   
(Early 90’s) Negative 
experimental clinical 
results of the Acroflex 
disc, with systematic 
failure of the elastomer 
in the sandwich 
configuration.  
Hip-like 
Ball-and-socket 
articulation 
between rigid 
materials. 
Motion (Early 90’s): 
- Positive clinical 
results of the SB 
Charité and 
Frenchay Hospital 
discs.  
- The ball-and-
socket configuration 
avoids the 
constraints in the 
elastomer typical of 
mimetic designs. 
No Load Absorption 
Hybrid 
Ball-and-socket 
articulation 
between an 
elatomer and 2 
metallic plates.  
Motion and a 
presumable 
amount of load 
absorption. 
(Invented in mid 
90’s): - A 
presumable amount 
of load absorption   
- The ball-and-
socket configuration 
avoids the 
constraints in the 
elastomer typical of 
the sandwich 
configuration in 
mimetic designs. 
- 
Table 1: Summary of Artificial Disk Design 
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Figure 7. The evolution of the artificial disc. The red line marks the emergence of each operational principle in clinical use. Source: own elaboration from [67, 
56, 65, 69, 77] 
